OTCMKTS:CPMD CannaPharmaRX (CPMD) Stock Price, News & Analysis $0.0044 0.00 (0.00%) As of 04/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About CannaPharmaRX Stock (OTCMKTS:CPMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CannaPharmaRX alerts:Sign Up Key Stats Today's Range$0.0044▼$0.004450-Day Range$0.0036▼$0.007052-Week Range$0.0001▼$0.0176VolumeN/AAverage Volume170,829 shsMarket Capitalization$2.92 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.Read More… Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPMD Stock News HeadlinesCannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comPSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 1, 2025 | Brownstone Research (Ad)CannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deCannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsMarch 12, 2024 | finanznachrichten.deSee More Headlines CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed this year? CannaPharmaRX's stock was trading at $0.0081 at the beginning of the year. Since then, CPMD stock has decreased by 45.7% and is now trading at $0.0044. View the best growth stocks for 2025 here. How were CannaPharmaRX's earnings last quarter? CannaPharmaRX, Inc. (OTCMKTS:CPMD) announced its quarterly earnings results on Thursday, April, 10th. The company reported ($0.01) EPS for the quarter. The business earned $0.48 million during the quarter. How do I buy shares of CannaPharmaRX? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CannaPharmaRX own? Based on aggregate information from My MarketBeat watchlists, some other companies that CannaPharmaRX investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI). Company Calendar Last Earnings4/10/2025Today5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CPMD CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.69 million Net MarginsN/A Pretax Margin408.11% Return on EquityN/A Return on Assets-41.99% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-0.15Miscellaneous Outstanding Shares662,501,000Free Float652,236,000Market Cap$2.92 million OptionableNot Optionable Beta2.35 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (OTCMKTS:CPMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.